Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Indian Bitter Gourd (Momordica charantia L.) is valued for its diverse bioactive compounds, including triterpenoids and peptides, which contribute to its antidiabetic and anti-inflammatory effects. These compounds modulate glucose metabolism by inhibiting glycolysis genes like GLUT-1 and reduce inflammation by inhibiting NF-κB and related cytokines.
Reported Benefits (Provisional)
Origin & History
Indian Bitter Gourd (Momordica charantia) is a tropical vine belonging to the Cucurbitaceae family. It is native to the tropical regions of India, thriving in warm, humid climates with well-drained, fertile soils. This fruit is highly valued in functional nutrition for its potent bioactive compounds that support metabolic and digestive health.
Research Narrative (Provisional)
Preliminary clinical trials and in vitro studies support Indian Bitter Gourd's efficacy in regulating blood glucose levels and enhancing insulin sensitivity. Further research, including larger-scale human trials, is ongoing to fully elucidate its mechanisms in immune and digestive health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamin C - Iron - Magnesium - Flavonoids (e.g., catechins, gallic acid) - Charantin - Polypeptide-p
Reported Mechanism (Provisional)
Indian Bitter Gourd's antidiabetic effects are primarily mediated by triterpenoids like cucurbitane-type compounds, which modulate glucose metabolism by inhibiting glycolysis genes such as GLUT-1 and PFKP. Peptides and proteins, including polypeptide-p and BG-4, contribute to its anti-inflammatory properties by inhibiting NF-κB pathways, thereby reducing pro-inflammatory cytokines like IL-6, IL-8, and TNF-α. Additionally, polysaccharides and phenolic compounds provide antioxidant and immune-enhancing benefits, further supporting cellular health and systemic balance.
Clinical Narrative (Provisional)
Preliminary clinical trials and extensive in vitro studies consistently support Indian Bitter Gourd's efficacy in regulating blood glucose levels and improving insulin sensitivity. These studies indicate its potential antidiabetic, anti-inflammatory, and antioxidant properties, suggesting broader therapeutic applications. While current evidence is promising, further larger-scale human trials are ongoing and needed to fully establish its long-term benefits and precise mechanisms across various health domains, including immune and digestive health.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.